Talazoparib is Effective in Neoadjuvant Setting | Combine PARP-Inhibitors w Immune Checkpoint

Talazoparib is Effective in Neoadjuvant Setting | Combine PARP-Inhibitors w Immune Checkpoint

Annual-Meeting

1 year
264 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Hope S. Rugo, MD, FAnnual Meeting, University of California, San Francisco explains Talazoparib is Effective in Neoadjuvant Setting | Combine PARP-Inhibitors w Immune Checkpoint at Annual Meeting 2018
Up Next Autoplay